207
Views
5
CrossRef citations to date
0
Altmetric
Review

Treatment of arterial ischemic stroke in children

, &
Pages 383-392 | Published online: 09 Jan 2014

References

  • Fullerton HJ, Wu YW, Zhao S, Johnston SC. Risk of stroke in children: ethnic and gender disparities. Neurology61(2), 189–194 (2003).
  • deVeber G. In pursuit of evidence-based treatments for paediatric stroke: the UK and CHEST guidelines. Lancet Neurol.4(7), 432–436 (2005).
  • Sebire G, Fullerton H, Riou E, deVeber G. Toward the definition of cerebral arteriopathies of childhood. Curr. Opin. Pediatr.16(6), 617–622 (2004).
  • Wraige E, Ganesan V, Pohl KR. Arterial dissection complicating tonsillectomy. Dev. Med. Child Neurol.45(9), 638–639 (2003).
  • Bowen MD, Burak CR, Barron TF. Childhood ischemic stroke in a nonurban population. J. Child Neurol.20(3), 194–197 (2005).
  • Kirkham F, Sebire G, Steinlin M, Strater R. Arterial ischaemic stroke in children. Review of the literature and strategies for future stroke studies. Thromb. Haemost.92(4), 697–706 (2004).
  • Chabrier S, Husson B, Lasjaunias P, Landrieu P, Tardieu M. Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients. J. Child Neurol. (5), 290–294 (2000).
  • Lanthier S, Carmant L, David M, Larbrisseau A, de Veber G. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology54(2), 371–378 (2000).
  • Ganesan V, Prengler M, McShane MA, Wade AM, Kirkham FJ. Investigation of risk factors in children with arterial ischemic stroke. Ann. Neurol. (2), 167–173 (2003).
  • Chung B, Wong V. Pediatric stroke among Hong Kong Chinese subjects. Pediatrics114(2) E206–E212 (2004).
  • Adams RJ, McKie VC, Hsu L et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N. Engl. J. Med.339(1), 5–11 (1998).
  • deVeber G, MacGregor D, Curtis R, Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J. Child Neurol. (5), 316–324 (2000).
  • Strater R, Becker S, von Eckardstein A et al. Prospective assessment of risk factors for recurrent stroke during childhood – a 5-year follow-up study. Lancet360(9345), 1540–1545 (2002).
  • Scothorn DJ, Price C, Schwartz D, et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J. Pediatr.140(3), 348–354 (2002).
  • Paediatric Stroke Working Group. Stroke in Childhood: Clinical Guidelines for Diagnosis, Management and Rehabilitation. Royal College of Physicians of London, London, UK (2004).
  • Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest126(Suppl. 3), S645–S687 (2004).
  • Kirkham FJ. Stroke in childhood. Arch. Dis. Child81(1), 85–89 (1999).
  • Riela AR, Roach ES. Etiology of stroke in children. J. Child Neurol.8(3), 201–220 (1993).
  • Lynch JK. Cerebrovascular disorders in children. Curr. Neurol. Neurosci. Rep.4(2), 129–138 (2004).
  • varez-Sabin J, Molina CA, Ribo M et al. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke35(11), 2493–2498 (2004).
  • Ribo M, Molina C, Montaner J et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke36(8), 1705–1709 (2005).
  • Gentile NT, Seftchick MW, Huynh T, Kruus LK, Gaughan J. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad. Emerg. Med.13(2), 174–180 (2006).
  • Baird TA, Parsons MW, Phanh T et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke34(9), 2208–2214 (2003).
  • Gray CS, Hildreth AJ, Alberti GK, O’Connell JE. Poststroke hyperglycemia: natural history and immediate management. Stroke35(1), 122–126 (2004).
  • Natale JE, Joseph JG, Helfaer MA, Shaffner DH. Early hyperthermia after traumatic brain injury in children: risk factors, influence on length of stay, and effect on short-term neurologic status. Crit. Care Med.28(7), 2608–2615 (2000).
  • Kammersgaard LP, Jorgensen HS, Rungby JA et al. Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen Stroke Study. Stroke33(7), 1759–1762 (2002).
  • Reith J, Jorgensen HS, Pedersen PM et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet347(8999), 422–425 (1996).
  • Castillo J, Davalos A, Marrugat J, Noya M. Timing for fever-related brain damage in acute ischemic stroke. Stroke29(12), 2455–2460 (1998).
  • Downard C, Hulka F, Mullins RJ et al. Relationship of cerebral perfusion pressure and survival in pediatric brain-injured patients. J. Trauma49(4), 654–658 (2000).
  • Cataltepe O, Vannucci RC, Heitjan DF, Towfighi J. Effect of status epilepticus on hypoxic-ischemic brain damage in the immature rat. Pediatr. Res.38(2), 251–257 (1995).
  • Wirrell EC, Armstrong EA, Osman LD, Yager JY. Prolonged seizures exacerbate perinatal hypoxic-ischemic brain damage. Pediatr. Res.50(4), 445–454 (2001).
  • Waterhouse EJ, Vaughan JK, Barnes TY et al. Synergistic effect of status epilepticus and ischemic brain injury on mortality. Pediatr. Res.29(3), 175–183 (1998).
  • Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology62(10), 1743–1748 (2004).
  • Hernandez TD, Holling LC. Disruption of behavioral recovery by the anti-convulsant phenobarbital. Brain Res.635(1–2), 300–306 (1994).
  • Goldstein LB. Potential effects of common drugs on stroke recovery. Arch. Neurol.55(4), 454–456 (1998).
  • Golomb MR, Rafay M, Armstrong D et al. Intra-arterial tissue plasminogen activator for thrombosis complicating cerebral angiography in a 17-year-old girl. J. Child Neurol.18(6), 420–423 (2003).
  • Carlson MD, Leber S, Deveikis J, Silverstein FS. Successful use of rt-PA in pediatric stroke. Neurology57(1), 157–158 (2001).
  • Gruber A, Nasel C, Lang W, Kitzmuller E, Bavinzski G, Czech T. Intra-arterial thrombolysis for the treatment of perioperative childhood cardioembolic stroke. Neurology54(8), 1684–1686 (2000).
  • Noser EA, Felberg RA, Alexandrov AV. Thrombolytic therapy in an adolescent ischemic stroke. J. Child Neurol.16(4), 286–288 (2001).
  • Bourekas EC, Slivka AP, Casavant MJ. Intra-arterial thrombolysis of a distal internal carotid artery occlusion in an adolescent. Neurocrit. Care2(2), 179–182 (2005).
  • Sungarian A, Duncan JA III. Vertebrobasilar thrombosis in children: report of two cases and recommendations for treatment. Pediatr. Neurosurg.38(1), 16–20 (2003).
  • International Pediatric Stroke Study Investigators. Thrombolysis in Children with Arterial Ischemic Stroke: initial results from the International Pediatric Stroke Study. Stroke38(2), 485 (2007) (Abstract).
  • Grotta JC, Burgin WS, El-Mitwalli A et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch. Neurol.58(12), 2009–2013 (2001).
  • Katzan IL, Furlan AJ, Lloyd LE et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA283(9), 1151–1158 (2000).
  • Kirton A, Wong JH, Mah J et al. Successful endovascular therapy for acute basilar thrombosis in an adolescent. Pediatrics112, E248–E251 (2003).
  • Gupta AA, Leaker M, Andrew M et al. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J. Pediatr.139(5), 682–688 (2001).
  • Coull BM, Williams LS, Goldstein LB et al. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Stroke33(7), 1934–1942 (2002).
  • Strater R, Kurnik K, Heller C, Schobess R, Luigs P, Nowak-Gottl U. Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study. Stroke32(11), 2554–2558 (2001).
  • Burak CR, Bowen MD, Barron TF. The use of enoxaparin in children with acute, nonhemorrhagic ischemic stroke. Pediatr. Neurol.29(4), 295–298 (2003).
  • Newall F, Barnes C, Ignjatovic V, Monagle P. Heparin-induced thrombocytopenia in children. J. Paediatr. Child Health39(4), 289–292 (2003).
  • Schmugge M, Risch L, Huber AR, Benn A, Fischer JE. Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients. Pediatrics109(1), E10 (2002).
  • Soman T, Rafay MF, Hune S, Allen A, MacGregor D, deVeber G. The risks and safety of clopidogrel in pediatric arterial ischemic stroke. Stroke37(4), 1120–1122 (2006).
  • Pegelow CH, Adams RJ, McKie V et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J. Pediatr.126(6), 896–899 (1995).
  • Nichols FT, Jones AM, Adams RJ. Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing. J. Neuroimaging11(4), 354–362 (2001).
  • Ohene-Frempong K. Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations. Semin. Hematol.28(3), 213–219 (1991).
  • Hulbert ML, Scothorn DJ, Panepinto JA et al. Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia. J. Pediatr.149(5), 710–712 (2006).
  • Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N. Engl. J. Med.353(26), 2769–2778 (2005).
  • deVeber G, Monagle P, Chan A et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch. Neurol.55(12), 1539–1543 (1998).
  • Bhatt DL, Fox KA, Hacke W et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N. Engl. J. Med.354(16), 1706–1717 (2006).
  • McQuaid KR, Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am. J. Med.119(8), 624–638 (2006).
  • Sacco RL, Adams R, Albers G et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of neurology affirms the value of this guideline. Stroke37(2), 577–617 (2006).
  • Walters MC, Storb R, Patience M et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood95(6), 1918–1924 (2000).
  • Qureshi N, Lubin B, Walters MC. The prevention and management of stroke in sickle cell anaemia. Expert Opin. Biol. Ther.6(11), 1087–1098 (2006).
  • Horn P, Pfister S, Bueltmann E, Vajkoczy P, Schmiedek P. Moyamoya-like vasculopathy (moyamoya syndrome) in children. Childs Nerv. Syst.20(6), 382–391 (2004).
  • Dobson SR, Holden KR, Nietert PJ et al. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood99(9), 3144–3150 (2002).
  • Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J. Neurosurg. Spine100(2), 142–149 (2004).
  • Isono M, Ishii K, Kamida T, Inoue R, Fujiki M, Kobayashi H. Long-term outcomes of pediatric moyamoya disease treated by encephalo-duro-arterio-synangiosis. Pediatr. Neurosurg.36(1), 14–21 (2002).
  • Houkin K, Kuroda S, Nakayama N. Cerebral revascularization for moyamoya disease in children. Neurosurg. Clin. N. Am.12(3), 575–584, ix (2001).
  • Thirumalai SS, Shubin RA. Successful treatment for stroke in a child using recombinant tissue plasminogen activator. J. Child Neurol.15(8), 588 (2000).
  • Cognard Weill A, Lindgren S, Piotin M, Castaings L, Moret J. Basilar artery occlusion in a child: "clot angioplasty" followed by thrombolysis. Childs Nerv Syst.16(8), 496–500 (2000).

Websites

  • World Health Organization – Cerebrovascular accident, stroke. www.who.int/topics/cerebrovascular_ accident/en/ (Accessed 1 January 2007)
  • PedNIHSS Validation of the NIH Stroke Scale in children. www.strokecenter.org/trials/TrialDetail.aspx?tid=722 (Accessed 28 January 2007)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.